ACC consensus pathway introduces stages A through D for myocarditis classification, paralleling the established heart failure staging system cardiologists use daily.
The 2025 Standards introduce continuous glucose monitoring recommendations for type 2 diabetes patients not on insulin therapy, while new guidance addresses religious fasting, automated insulin delivery in pregnancy, and specific blood glucose targets for hospitalized patients.
An international expert panel introduces the first consensus recommendations for diagnosing and treating chronic non-bacterial osteitis (CNO) in adults - consolidating multiple disease labels into a single entity and establishing evidence-based protocols.
"If the pharmaceutical industry had developed a single drug capable of reducing cancer mortality by 25%, autoimmune disorders by 39%, and COVID-19 infection rates by 74%, it would be heralded as a miracle drug."
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
The AGA now suggests early use of advanced therapies rather than gradual step-up with 5-ASAs in moderate-to-severe UC, emphasizing this approach in its latest recommendations.
ACR's 2024 lupus nephritis guidelines signal a shift to a triple therapy approach, moving away from traditional dual immunosuppressive treatment while proposing shorter steroid courses.
"The components of the CHA2DS2-VASc score are so prevalent in HD patients with AF that most qualify for OAC if the guidelines are applied" - an observation from the study that challenges conventional risk assessment approaches for this high-risk population.
None of the 179 first aid recommendations in the 2024 AHA/Red Cross guidelines achieved Level A evidence support, highlighting critical research gaps in foundational emergency care practices.